Урогенитальные заболевания, вызванные генитальными микоплазмами (Mycoplasma genitalium, Ureaplasma spp., Mycoplasma hominis)

1. Robertson JA et al. Expanded serotyping scheme for Ureaplasma urealyticum strains isolated from humans. J Clin Microbiol 1982; 15: 873–8.
2. Robertson JA et al. Polymerase chain reaction using 16S rRNA gene sequences distinguishes the two biovars of Ureaplasma urealyticum. J Clin Microbiol 1993; 31: 824–30.
3. Robertson JA et al. Proposal of Ureaplasma parvum sp. nov. and emended description of Ureaplasma urealyticum (Shepard M et al. 1974). Int J Syst Evol Microbiol 2002; 52: 587–97.
4. Oakeshott P, Aghaizu A, Hay P et al. Is Mycoplasma genitalium in Women the «New Chlamydia?». A Community-Based Prospective Cohort Study. Clin Infect Dis 2010 15; 51 (10): 1160–6.
5. Cohen CR, Manhart LE, Bukusi EA et al. Association between Mycoplasma genitalium and acute endometritis. Lancet 2002; 359 (9308): 765–6.
6. Haggerty CL, Totten PA, Astete SG, Ness RB. Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease. Infect Dis Obstet Gynecol 2006; 2006: 30184.
7. Henry CH, Hughes CV, Gerard HC et al. Reactive arthritis: preliminary microbiologic analysis of the human temporomandibular joint. J Oral Maxillofac Surg 2000; 58 (10): 1137–42; discussion 43–4.
8. Yokoi S, Maeda S, Kubota Y et al. The role of Mycoplasma genitalium and Ureaplasma urealyticum biovar 2 in postgonococcal urethritis. Clin Infect Dis 2007; 45 (7): 866–71.
9. Povlsen K, Bjornelius E, Lidbrink P, Lind I. Relationship of Ureaplasma urealyticum biovar 2 to nongonococcal urethritis. Eur J Clin Microbiol Infect Dis 2002; 21 (2): 97–101.
10. WHO 2006. Global strategy for the prevention and control of sexually transmitted infections: 2006–2015: breaking the chain of transmission. Available at: http://whqlibdoc.who.int/publications/2007/9789244563472_rus.pdf. last access 19, Sept 2010.
11. Centers for Disease Control and Prevention. STD Treatment Guidelines 2010. Morbidity and Mortality Weekly Report (MMWR) 2010; 59 (RR-12): 1–114.
12. Manhart LE, Critchlow CW, Holmes KK et al. Mucopurulent cervicitis and Mycoplasma genitalium. J Infect Dis 2003; 187 (4): 650–7.
13. McGowin CL, Spagnuolo RA, Pyles RB. Mycoplasma genitalium rapidly disseminates to the upper reproductive tracts and knees of female mice following vaginal inoculation. Infection and immunity 2010; 78 (2): 726–36. Preliminary microbiologic analysis of the human temporomandibular joint. J Oral Maxillofac Surg 2000; 58 (10): 1137–42; discussion 43–4.
14. Taylor-Robinson D, Renton A, Jensen JS et al. Association of Mycoplasma genitalium with acute non-gonococcal urethritis in Russian men: a comparison with gonococcal and chlamydial urethritis. Int J STD & AIDS 2009; 20 (4): 234–7.
15. Manhart LE, Golden MR, Marrazzo JM. Expanding the spectrum of pathogens in urethritis: implications for presumptive therapy? Clin Infect Dis 2007; 45 (7): 872–4.
16. Савичева АМ, Шипицына ЕВ, Золотоверхая ЕА et al. Лабораторная диагностика инфекции, вызванной Mycoplasma genitalium. Метод. рекомендации. СПб.: Н-Л, 2010.
17. Shipitsyna E, Savicheva A, Solokovskiy E et al. Guidelines for the laboratory diagnosis of Mycoplasma genitalium infections in East European countries. Acta Derm Venereol 2010; 90 (5): 461–7.
18. Савичева А.М., Соколовский Е.В., Домейка М. и др. Методические материалы по диагностике, лечению и профилактике наиболее распространенных инфекций, передаваемых половым путем. Методич. пособие. СПб: Н-Л, 2002.
19. Гущин А.Е., Бурцев О.А., Рыжих П.Г. и др. Мониторинг лечения пациентов с инфекцией, вызванной Mycoplasma genitalium с помощью методов ПЦР и НАСБА в реальном времени. Клинич. дерматол. и венерол. 2009; 4: 58–63.
20. Bjornelius E, Anagrius C, Bojs G et al. Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial. Sex Transm Infect 2008; 84 (1): 72–6.
21. Bradshaw CS, Chen MY, Fairley CK. Persistence of Mycoplasma genitalium following azithromycin therapy. PLoS ONE 2008; 3 (11): e3618.
22. Skerk V, Schonwald S, Krhen I et al. Azithromycin and doxycycline in the treatment of female patients with acute urethral syndrome caused by Ureaplasma urealyticum: significance of duration of clinical symptoms. Drugs Exp Clin Res 2001; 27 (4): 135–9.
23. Савичева А.М., Чхартишвили М.Г., Золотоверхая Е.А., Шипицына Е.В. Эффективность доксициклина при лечении урогенитальных инфекций, ассоциированных с уреаплазмами. Гинекология. 2009; 11 (6): 38–41.
24. Ogasawara KK, Goodwin TM. Efficacy of azithromycin in reducing lower genital Ureaplasma urealyticum colonization in women at risk for preterm delivery. J Matern Fetal Med 1999; 8 (1): 12–6.
25. Krausse R, Schubert S. In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years. Clin Microbiol Infect 2010; 16 (11): 1649–55.

М.Р.Рахматулина
ФГБУ Государственный научный центр дерматовенерологии и косметологии, Москва